This session will cover key concepts related to implementing intensity modulated radiotherapy (IMRT) and stereotactic body radiotherapy (SBRT) gastrointestinal (GI) cancers. Updates on clinical outcome data using IMRT and SBRT, including survival and toxicity, will be presented.

This course will review current and epidemiological changes in esophageal and gastric cancer as well as discuss current and future multimodality treatment strategies.

IJROBP Journal SA-CME activity for May 1, 2017 (Volume 98, Issue 1) explores patient safety and clinical research related to efficacy of stereotactic ablative radiotherapy for management of metastatic renal cell carcinoma.

Pages

Subscribe to RSS - Gastrointestinal